Alexander Waite
Family Medicine · Dobson, NCNPI 1700043288
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.4% of the total across 102 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 19.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $558 and has fallen 97.0% since, to $17 in 2023.
Across 102 payments — averaging $14.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$287
- Pfizer$213
- Amgen$195
- AbbVie$173
- GSK$125
- Novo Nordisk$75
- plus $389 from 13 others
What the payments were for
- Food & beverage$1,43498%
- Education$232%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 26 | $287 |
| Pfizer | 13 | $213 |
| Amgen | 12 | $195 |
| AbbVie(2 entities) | 12 | $173 |
| GSK | 8 | $125 |
| Novo Nordisk | 5 | $75 |
| AstraZeneca | 5 | $65 |
| Sanofi-aventis U.S. LLC | 3 | $44 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $42 |
| Boehringer Ingelheim | 2 | $39 |
| Ironwood Pharmaceuticals, Inc | 2 | $34 |
| Novartis | 2 | $32 |
| Bayer | 2 | $31 |
| Nestle Healthcare Nutrition Inc. | 2 | $25 |
| Abbott | 1 | $24 |
| Merck | 1 | $15 |
| Eisai Inc. | 1 | $13 |
| Promius Pharma LLC | 1 | $13 |
| Teva Pharmaceuticals USA, Inc. | 1 | $12 |
How this compares
$1,457 in reported general payments places this provider in the 75th percentile of 3,444 family medicine providers in North Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Metoprolol Succinate | 13 | $508 |
| Lovastatin | 13 | $221 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Dobson
- William CromwellRaleigh$879K
- Steve VacalisGastonia$693K
- David DundeeWinston Salem$633K
- Kevin SodenCharlotte$558K
- Brian ForrestApex$398K
- Joseph KonenCharlotte$322K
- Richard RachimaCharlotte$294K
- Dimitrios HondrosCharlotte$275K
- Domingo Rodriguez-CueGarner$253K
- Christopher ChaoCary$201K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.